1. Home
  2. VCIG vs TRIB Comparison

VCIG vs TRIB Comparison

Compare VCIG & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VCI Global Limited

VCIG

VCI Global Limited

SELL

Current Price

$9.20

Market Cap

12.5M

ML Signal

SELL

TRIB

Trinity Biotech plc

HOLD

Current Price

$0.71

Market Cap

14.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCIG
TRIB
Founded
2013
1992
Country
Malaysia
Ireland
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5M
14.0M
IPO Year
2022
1996

Fundamental Metrics

Financial Performance
Metric
VCIG
TRIB
Price
$9.20
$0.71
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.0M
151.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$13.51
Revenue Next Year
N/A
$13.14
P/E Ratio
$1.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.48
52 Week High
$15.45
$3.44

Technical Indicators

Market Signals
Indicator
VCIG
TRIB
Relative Strength Index (RSI) 96.34 41.80
Support Level $0.75 $0.68
Resistance Level $15.45 $0.80
Average True Range (ATR) 0.25 0.06
MACD 0.57 -0.00
Stochastic Oscillator 82.08 28.79

Price Performance

Historical Comparison
VCIG
TRIB

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

Share on Social Networks: